Navigation Links
Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
Date:9/12/2011

SAN DIEGO, Sept. 12, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced that the Company will provide an update on the DIFICID™ (fidaxomicin) tablets launch at the Morgan Stanley Global Healthcare Conference taking place in New York City. Pedro Lichtinger, Optimer's President and CEO, will comment on the DIFICID launch tomorrow, September 13, during a webcasted fireside chat at 8:00 AM ET. DIFICID was approved by the U.S. Food and Drug Administration in May of 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and DIFICID is the first antibacterial drug approved for the treatment of CDAD in 25 years.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

"We believe the Optimer strategy is proving highly impactful, with DIFICID sales exceeding published analyst expectations in the initial stages of the launch. While early in the launch, we view it as a major success to date. We are committed to maintaining this momentum as the launch matures," said Pedro Lichtinger, president and CEO of Optimer Pharmaceuticals. "The growing evidence of the value of DIFICID to patients, hospitals and payers  is being well received by practitioners and other stakeholders. Supported by DIFICID's clinical strength and value proposition, we believe the combined Optimer/Cubist field presence is having a material impact on accelerating prescriptions and formulary adoption."

There are several key components comprising the DIFICID launch effort and Optimer plans to review progress to date for each of those components.

1. DIFICID Sales

For the period of July 19, the date of DIFICID's first sales, through September 2 , Optimer estimates DIFICID gross sales of $
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
2. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
3. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4. Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimers DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
5. Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results
6. Optimer Launches DIFICID™ (fidaxomicin) Tablets for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in Patients 18 Years of Age and Older
7. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8. Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
9. Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
10. Optimer Pharmaceuticals Expands Senior Management Team
11. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... GRAND RAPIDS, Mich. , Jan. 15, 2014 As ... of the flu virus, select Meijer pharmacies in ... and strep throat to eligible patients, enabling Meijer pharmacists to ... under strict protocol set by a physician participating in the ...
(Date:1/15/2014)...  Novation, the leading health care supply chain expertise, analytics ... (VAR) national contracts that expand its portfolio to provide ... costs. These include manufacturer product and service agreements, as ... ongoing IT consulting support. New Novation ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2
... Calif., April 13, 2011 Two new studies published ... and Related Diseases, a peer-reviewed journal, add to ... the LAP-BAND® Adjustable Gastric Banding System, made by Allergan, ... and effective weight-loss procedure. One study concluded that laparoscopic ...
... 13, 2011 / PRNewswire / -- ... today announced the Ion OneTouch System, an automated sample preparation system ... complexity, reduces hands-on time to five minutes and offers walk-away ... introductory price of under $5,000; the first shipments will be ...
Cached Medicine Technology:New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 2New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 3New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 4New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 5New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 6New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 7New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 8New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 9Life Technologies Announces an Automated Sample Preparation System for its Ion PGM™ Sequencer 2Life Technologies Announces an Automated Sample Preparation System for its Ion PGM™ Sequencer 3Life Technologies Announces an Automated Sample Preparation System for its Ion PGM™ Sequencer 4
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently ... molecule in metastatic breast cancer reduces both the growth ... BRI scientists have found in models of the disease ... - 80 percent and can keep the tumor from ... five-year grant comes from the National Cancer Institute of ...
(Date:4/18/2014)... to potential new treatments for breaking the cycle of ... or scarring, is a hallmark of the disease, and ... to serious organ damage and, in some cases, death. ... findings made by Swati Bhattacharyya, PhD, research assistant professor ... protein plays in promoting fibrosis. , "Our results ...
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... University of California, San Diego School of Medicine report ... suffered a recent major loss are more likely to ... The study is published in this month,s issue of ... Because compassionate behaviors are associated with better health and ... into ways to improve the outcomes of individuals whose ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2
... interventions to Vietnamese populationsFREMONT, Calif., March 18 The ... NCCC ) ... first-of-its-kind study of interventions to improve colon cancer screening ... to non-Hispanic whites. NCCC Scientist Bang Nguyen, Dr.P.H. ...
... successful projects. , ... Orinda, CA (PRWEB) March 18, ... allocates billions of dollars to the NIH, NSF, NIST, DOE and ... research facilities. These funds will be distributed to research institutions ...
... rate for combo surgery, , , WEDNESDAY, March 18 (HealthDay ... people who would benefit from a combined heart and ... "In the past, patients with end-stage heart failure having ... heart transplantation," Dr. Mark J. Russo, of Columbia University ...
... prostate cancer can reduce deaths by 20%, according to ... for Prostate Cancer (ERSPC) published online 1700 hours CET, ... world,s largest prostate cancer screening study and provides robust, ... effect of screening on prostate cancer mortality. , The ...
... a common medical condition characterized by convulsions and short ... people worldwide. But intractable epilepsy, which affects more than ... treatment and surgery, is arguably worse. ... unique nerve-stimulation treatment for intractable epilepsy reduced the number ...
... YORK, March 18 HMS Holdings Corp. (Nasdaq: ... at the Sidoti & Co. 13th Annual New York ... New York City.The Company will present on Wednesday, March ... is the leader in coordination of benefits and program ...
Cached Medicine News:Health News:Northern California Cancer Center Study Seeks to Improve Colon Cancer Screening in Vietnamese Communities 2Health News:Stimulus Spending Targets Modernization of the Nation's Research Infrastructure 2Health News:Stimulus Spending Targets Modernization of the Nation's Research Infrastructure 3Health News:Guidelines Suggested for Heart-Kidney Transplants 2Health News:PSA screening cuts deaths by 20 percent 2Health News:Unique nerve-stimulation device proves effective against epilepsy 2
Peapod Rongeur, 5.5 length 140 mm....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
Mayfield Disposable Adult (plastic) Skull Pins are designed for rigid skeletal fixation....
... Karl Storz borescopes are rigid endoscopes for general ... lens system. The diameters of borescopes, i.e. rigid ... with viewing directions from 0 up to a ... zoom lens and wide angle view. Endoscopes with ...
Medicine Products: